During the last session, Agilon Health Inc (NYSE:AGL)’s traded shares were 5.38 million, with the beta value of the company hitting 0.17. At the end of the trading day, the stock’s price was $2.23, reflecting an intraday loss of -5.11% or -$0.12. The 52-week high for the AGL share is $7.73, that puts it down -246.64 from that peak though still a striking 32.74% gain since the share price plummeted to a 52-week low of $1.50. The company’s market capitalization is $923.12M, and the average intraday trading volume over the past 10 days was 5.22 million shares, and the average trade volume was 5.93 million shares over the past three months.
Agilon Health Inc (AGL) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.80. AGL has a Sell rating from 0 analyst(s) out of 10 analysts who have looked at this stock. 3 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 7 recommend a Buy rating for it.
Agilon Health Inc (NYSE:AGL) trade information
Agilon Health Inc (AGL) registered a -5.11% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -5.11% in intraday trading to $2.23, hitting a weekly high. The stock’s 5-day price performance is -5.11%, and it has moved by -41.32% in 30 days. Based on these gigs, the overall price performance for the year is -63.38%. The short interest in Agilon Health Inc (NYSE:AGL) is 22.2 million shares and it means that shorts have 3.65 day(s) to cover.
The consensus price target of analysts on Wall Street is $4, which implies an increase of 44.25% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.5 and $6.5 respectively. As a result, AGL is trading at a discount of -191.48% off the target high and -12.11% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 3.29%. While earnings are projected to return 45.00% in 2025, the next five years will return 41.90% per annum.
AGL Dividends
Agilon Health Inc is due to release its next quarterly earnings on 2025-May-05. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Agilon Health Inc (NYSE:AGL)’s Major holders
Agilon Health Inc insiders own 1.99% of total outstanding shares while institutional holders control 97.67%, with the float percentage being 99.65%. CLAYTON, DUBILIER & RICE, LLC is the largest shareholder of the company, while 272.0 institutions own stock in it. As of 2024-06-30, the company held over 100.0 million shares (or 24.3149% of all shares), a total value of $654.0 million in shares.
The next largest institutional holding, with 56.93 million shares, is of FMR LLC’s that is approximately 13.8418% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $372.3 million.
Also, the Mutual Funds coming in first place with the largest holdings of Agilon Health Inc (AGL) shares are VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and SMALLCAP WORLD FUND INC. Data provided on Jan 31, 2025 indicates that VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund owns about 33.09 shares. This amounts to just over 7.99 percent of the company’s overall shares, with a $73.78 million market value. The same data shows that the other fund manager holds slightly less at 30.86, or about 7.46% of the stock, which is worth about $68.83 million.
